Increased TGFβ activity may suppress antitumor response through inhibiting CD4 + T helper cell function (TH1 and TH2), decreasing differentiation and function of cytotoxic T cells, promoting pro-tumor TH17 response, and recruiting immune suppressive myeloid cells into the tumor microenvironment [13]. This evidence concerns the gene CD4 and neoplasm.